SlideShare a Scribd company logo
Infective Endocarditis
Definition 
• Conditions in which structures of the heart, most 
frequently the valves, harbor an infective process. 
• This might lead to: 
– Valvar dysfunction 
– Localized or generalized sepsis 
– Sites for embolism 
• The term “Infective Endocarditis” includes: 
– Acute, subacute, and chronic 
– Bacterial, viral, rickettsial, or fungal 
– Native or prosthetic
Definition 
• Endocarditis: 
– Exudative and proliferative inflammatory 
alterations of the endocardium 
– Characterized by vegetations on the endocardial 
surface or within the endocardium 
– May occur as the primary disorder (infective 
endocarditis) or as a secondary complication of 
another disease (SLE, Rheumatic Heart Disease)
Definition 
• Infective Endocarditis: 
– Invasion and multiplication of micro-organisms on 
the endocardial surface, within the endocardium, 
within the myocardium, or on prosthetic materials 
within and around cardiac structures 
– Most frequently involves the valvar structures and 
it may lead to destruction of these structures, 
localized or genertalized sepsis, or sites of 
embolism
Pathogenesis 
• The most common site of involvement is on the 
line of closure of the valves 
– Atrial side of the atrio-ventricular valves 
– Ventricular side of the semilunar valves 
• Maturation of the vegetation: 
– Bacterial attachment 
– Bacterial proliferation + fibrin deposition 
• The bacteria remain below the surface of the 
vegetation and this protects them from: 
– Phagocytes 
– High antibiotic concentrations
Pathogenesis 
• Altered Endocardial Surface to allow deposition of 
bacteria and fibrin: 
– Rheumatic Valvulitis 
– Annular or Valvar Calcification 
– Catheter Trauma 
• Haemodynamic Factors: 
– Jet effect of blood flow through 
• PDA 
• Restrictive VSD 
• Mitral Valve Prolapse 
• BAV 
• Bacteraemia : 60-80% of normal individuals
Pathogenesis 
• Compromised or Altered Immune System 
– Histopathologic analysis of kidney tissue of the 
patients with IE: 
• Diffuse proliferative glumerolonephritis 
• Evidence of deposition of IgG and IgM 
• Circulating immune complexes (CICs) may be found in the: 
– Glomerular basement membrane 
– Retina 
– Peripheral lesions (Janeway lesions and Roth Spots) 
• CIC Levels correlate with the duration of the illness 
• Drop in CIC levels correlate with the success of the 
treatment 
– Various manifestations of complement activation
Pathogenesis 
• 25% of IE happen in normal valves 
– Organisms involved are those with increased adhesions 
molecules: 
• Staphylococcus 
• Streptococcus Viridans 
• Enterococcus 
– Common Risk Factors: 
• Overwhelming Sepsis 
• Resuscitation from Shock 
• Use of Long-Term IDCs 
• IVDU 
• Fungemia associated with prolonged ABx use 
• Only 5% of patients with IDC sepsis have endocarditis and it 
is usually due to Staphylococcal Organisms.
Pathogenesis 
• Iathrogenic IE: 
– Those undergoing chronic hemodialysis 
– Frequent Staphylococcal bacteremia 
– Sclerotic Aortic/Mitral Valves
Rodbard Hypothesis for Pathogenesis 
PART III Acquired Valvar 674 Heart Disease 
Orifice Sink 
Vena contracta 
Source 
Figure 15-1 Flow through a permeable tube. High-pressure source 
drives fluid through an orifice into a low-pressure sink. Curved 
arrows leaving the stream entering wall in upstream segment rep-resent 
normal perfusion of lining layer. Velocity is maximal and 
perfusing pressure is low immediately beyond orifice, where 
momentum of stream converges stream lines to form a vena con-tracta. 
Low pressure in this segment results in reduced perfusion 
and may cause retrograde flow from deeper layers of vessel into the 
flowing stream. It is at the vena contracta that bacteria and other 
formed elements in blood accumulate. (From Rodbard.R4) 
• High velocity jets of blood from a high-pressure source 
form at an orifice and enter a low-pressure sink 
• Venturi currents deposit bacteria immediately beyond 
the orifice to form vena contracta and result in 
mechanical erosion and deposition of platelets and 
thrombin
Pathogenesis 
• The same mechanism 
exists 
– Against the stenotic valves 
– Opposite to a PDA in 
pulmonary artery 
– Left atrial side of the 
regurgitant mitral valve. 
• Most IE lesions of aortic 
valve happen on the 
ventricular side which 
suggest the a role for 
valvar regurgitation and 
also the venturi effect
Morphology 
• Vegetations and eorsive cavities are on the: 
– Ventricular aspect of the aortic valve cusps 
– Base of the atrial side of the mitral valve leaflets 
• Often causing separation or discontinuity at the 
– Ventriculoarterial junction 
– Atrioventricular junction 
– Drop Lesions from the aortic valve vegetations occur 
on the anterior leaflet of the mitral valve and the 
tensor apparatus. 
– Discrete perforations also occur by isolated 
vegetations.
Aortic valve with 
vegetation on non-coronary 
cusp and 
partial destruction 
of left coronary 
cusp.
Aortic valve with 
vegetation 
between non-coronary 
and right 
coronary cusps 
extending as an 
anular abscess
Leaflet vegetation 
and ring abscess of 
posterior medial 
aspect of mitral 
valve
Mitral valve with 
drop lesion of 
anterior leaflet
Morphology 
• NVE: 
– Non-IV-Drug-Related: 
• Left Sided 
– IV-Drug-Related: 
• Tricuspid Valve 50% 
• Aortic and Mitral 50% 
• Perianular Abscess (Pseudoaneurysm): 
– More common with aortic valve endocarditis than it is with mitral 
– It is present in 1/3 of cases studied with TOE 
– Predominant organism is : S. aureus 
– Clinical features: 
• Presence of pericarditis 
• Rapid progression of the disease 
• High degree of AV Block
Morphology 
• PVE: 
– All or most of the vegetations are on the ventricular 
aspect 
– Only a small area of sewing ring detachment might be 
apparent and it might appear sterile 
– A thorough search at operation must be made 
beneath the valve to identify the bulk of the 
pathologic process 
– There may be important detachment without 
vegetation. This might be in the absence of an abscess 
or even positive blood culture.
Loci of Infective Endocarditis Lesions
Clinical Features 
• IE is present when 
– Positive blood cultures associated with: 
• New or changing murmurs 
• Embolic phenomena 
– New or changing murmurs in a patient with congenital 
cardiac anomaly or prior valve damage associated 
with: 
• Embolic phenomena 
• Sustained fever, anemia, and splenomegaly 
– Some authorities also accept the presence of 
progressive heart failure in the presence of positive 
blood cultures.
Duke’s Criteria - Major 
• Positive blood culture 
– Typical MOs for IE from 2 separate blood cultures in 
the absence of a primary focus: 
• Strep Viridans, Strep Bovis, HACEK (Haemophilus, 
Actinobacillus, Cardiobacterium, Eikenella, and Kingella), 
Community-acquired staph aureus, or Enterococci 
– Persistently positive blood cultures, defined as 
recovery of a microorganism consistent with IE from: 
• Blood cultures drawn more than 12 hours apart 
• All of three or majority of 4 or more separate blood 
cultures with first and last drawn at least 1 hour apart
Duke’s Criteria - Major 
• Evidence of Endocardial Involvement: 
– Positive echocardiogram for infective endocarditis: 
• Oscillating intra-cardiac mass in absence of an alternative 
anatomic explanation: 
– On valve or supporting structures 
– In path of regurgitant jets 
– On implanted material 
• Abscess 
• New partial dehiscence of prosthetic valve 
• New valvar regurgitation (increase or change in preexisting 
murmur not sufficient for diagnosis)
Duke’s Criteria - Minor 
• Predisposition: 
– Predisposing heart 
condition or IV drug use 
– Fever ≥38°C 
• Vascular Phenomena: 
– Major arterial emboli 
– Septic pulmonary infarcts 
– Mycotic aneurysm 
– Intracranial hemorrhage 
– Conjunctival 
hemorrhages 
– Janeway lesions
Duke’s Criteria - Minor 
• Immunologic 
Phenomena: 
– Glomerulonephritis 
– Osler nodes 
– Roth spots 
– Rheumatoid factor
Duke’s Criteria - Minor 
• Microbiological Evidence: 
– Positive blood cultures but not meeting the major 
criterion 
– Serologic evidence of active infection with a MO 
consistent with IE 
• Echocardiogram: 
– Consistent with infective endocarditis but not 
meeting major criterion
Clinical Feature 
• Fever: 
– The most common clinical manifestation 
– 95-100% present 
– Low-grade 
– Spiking 
– Following the peak of bacteremia by 2 hours 
– Those at risk of IE who develop fever for more than 48 hours should have 2 or 
more sets of blood cultures drawn from different sites 
• Positive blood cultures: 
– 95% of cases even when those with right-sided IE, fungal IE, IE in addicts, IE 
caused by fastidious organisms are included. 
• Culture negative IE: 10% 
– Mostly in those with PVE 
– Intracellular or fastidious organisms 
– Previous antibiotic therapy 
– A history of AB therapy and serologic evidence of mycoplasma, or chlamydia 
– Other causes: 
• Aspergillus, Q-fever, Bartonella
Clinical Feature 
• Heart Murmur: 
– 85-95% 
– 10% lack murmur 
– Aortic root and valve: 
• Short Diastolic Murmur 
• Early systolic or midsystolic murmurs also can be present 
– Mitral valve: 
• Like other MR, systolic murmurs and in the case of anterior leaflet drop lesions there is a 
distinct radiation to the back. 
• Diastolic murmurs like MS: obstruction with large vegetation. 
• Anemia 
– Multifactorial causes: Marrow suppression as a result of the chronic disease 
• Arthralgia / Arthritis : rarely seen today as a result of earlier diagnosis of 
the condition 
• Myalgia: common 
– Associated with bacteremia 
– Occasionally may result from myocardial microabscesses which generally 
happen in staph bacteremia
Clinical Feature 
• Embolic Phenomenon: 
– 10-15% presenting manifestation 
– 50% of patients with IE have embolic phenomenon: 
• Diagnosed on either clinical examination or by an imaging modality 
• Evenly distributed between cerebral and peripheral sites 
• Classic ones are now rarely seen in surgical practice: 
– Osler Nodes 
– Janeway Lesions : Staph almost always is the organism 
– Roth Spots 
– Petechiae 
– Clubbing 
• Neurologic Abnormalities: 25-30% of patients at initial 
presentation: 
– TIA/Stroke/Loss of Vision/Seizures/Headache/Backache/Acute 
Mononeuropathy
Causative Organisms 
• Strep and Staph : 80% of cases 
– S. aureus: 
• The most common cause of IE amongst hospital-acquired and drug-related 
• Mitral > Aortic 
• Higher occurrence of embolism comparing to the other oranisms 
– Strep: 
• 30% of IE cases 
• Viridans is the most common 
• Enterococci: 
– The third common 
– 10% of cases 
– Elderly male 
– Multiple comorbidities 
– Less common embolic events 
– More avidity to Aortic Valve 
• Gram-negative bacilli: 
– 5% of cases
Causative Organisms 
• PVE: 
– 2 months post-op: Staph. Epidermidis 
– Late onset: as NVE 
– Enterococcal: 
• E. Faecalis/ E. Faecium 
• Associated with manipulation of GI or GU tract 
• GI or GU tract malignancy
Complications 
• Heart Failure 
• Renal 
• Embolic Events 
• Neurologic Manifestations
Heart Failure 
• The most common 
• Valvular regurgitation is the cause 
• NVE occasionally results is MS and/or TS and infrequently AS 
• Perianular Extension 
– Major causes of heart failure in PVE. 
– 50% of cases with PVE 
– 10-40% of NVE 
– More commonly involves the aortic valve 
– Can lead to: 
• Abscess formation / pseudoaneurysm/aortocavitary fistula 
• Myocardial abscess: 
– S. aureus 
– PVE / Aortic Valve / BAV 
– Development of conduction abnormalities should prompt further TOE 
examination 
– Untreated: fistula formation and intracardiac shunting from myocardial 
perforation
Renal 
• At least in 4 forms: 
– Pre-renal due to low cardiac output 
– Microabscess formation secondary to septic 
emboli 
– Golmerular dysfunction as a result of CIC 
– Renal failure as a result of ABx
Embolic Events 
• Common: 
– NVE : 43% 
– IV Drug-Associated : 67% 
– PVE: 25%
Embolic Events 
• Metastatic infection of viscera is typically caused by Staph. 
• Multiple Coronary emboli: 
– MI 
– Ventricular Dysfunction 
– Most common causative organisms: 
• S. Aureus 
• Candida 
• HACEK (Hemophilus, Actinobacillus, Cardiobacterium, Eikenella, Kingella) 
• Neurologic Manifestations: 
– 50% of embolic complications are associated with neurologic manifestations 
– 1/4 – 1/3 of patients with NVE or PVE at some time have neurologic 
complications of which 90% are related to emboli in the territory of MCA 
– S. aureus increases the risk 
– Stroke is the most common neurologic event
Embolic Neurologic Events 
• Cerebral embolism generally happens before the start of antibiotic therapy and 
the risk dramatically falls following the commencement of an effective therapy. 
– The risk falls from ~ 12% to 4% 
• The absolute size of vegetation and failure of decrease in size of the vegetation 
following ABx is a risk for embolization. 
• HACEK Group and fungi create the large vegetation.
Intracerebral Hemorrhage 
• The most devastating complication 
• 5% of IE 
• 50% mortality 
• Pathophysiology: 
– Septic arteritis with erosion of the vessel wall 
during uncontrolled infection 
– Hemorrhage following infarction 
– Rupture of mycotic aneurysm
Treatment 
• Antibiotics: 
– > 50% of cases can be managed solely with antibiotics 
– Once antibiotics started blood cultures should be taken every 1- 
2 days and the length of the treatment should be calculated 
based on the date the blood cultures have become negative 
• Surgery: 
– It is necessary in 40-45% of patients 
– Goals: 
• Remove infected tissues and drain abscesses 
• Restore or reconstruct atrioventricular or ventriculo-arterial continuity 
• Reverse the haemodynamic abnormality 
• Closing the acquired defect / in children: repair of congenital 
malformation
Indications for Surgery 
• NVE: 
– Healed: those hemodynamic indications present for 
those without IE and similar valvular lesions 
– Active: 
• Congestive Heart Failure 
• Perianular Extension 
• Systemic Embolism 
• Cerebrovascular Complications 
• Persistent Sepsis 
• Difficult Organisms 
• PVE
Indications for Surgery 
• Congestive Heart Failure: 
– Caused by severe aortic or mitral regurgitation, 
more rarely by valve obstruction caused by 
vegetations. 
– Severe acute aortic or mitral regurgitation with 
echocardiographic signs of elevated left 
ventricular end-diastolic pressure or significant 
pulmonary hypertension. 
– As a result of prosthetic dehiscence or 
obstruction.
Indications for Surgery 
• Perianular Extension 
• Systemic Embolism 
– Recurrent emboli despite appropriate antibiotic 
therapy. 
– Large vegetations (>10 mm) after one or more clinical 
or silent embolic events after initiation of antibiotic 
therapy 
– Large vegetations and other predictors of a 
complicated course 
– Very large vegetations (>15 mm) without embolic 
complications, especially if valve-sparing surgery is 
likely (remains controversial)
Indications for Surgery 
• Cerebrovascular Complications 
– Silent neurologic complication or TIA and other 
surgical indications 
– Ischemic stroke and other surgical indications 
(hemorrhage should have been excluded and the 
neurologic complications are not severe and there 
is a chance for recovery)
Indications for Surgery 
• Persistent Sepsis: 
– Fever or positive blood cultures persisting > 5-7 
days despite appropriate antibiotic regimen, 
assuming that vegetations or other cardiac lesions 
requiring surgery persist and extracardiac sources 
of sepsis have all been excluded 
– Relapsing infective endocarditis, esp. when caused 
by organisms other than sensitive strep or in 
patients with prosthetic valves
Indications for Surgery 
• Difficult Organisms: 
– S. aureus involving a prosthetic valve and most cases 
involving a native valve 
– IE caused by other aggressive organisms: 
• Brucella 
• Stpahylococcus Lugdunensis 
– IE caused by MRO: 
• MRSA 
• VRE 
– P. aeruginosa IE 
– Fungal IE 
– Q Fever IE at the presence of other indications for 
intervention
Indications for Surgery 
• Prosthetic valve endocarditis: 
– All cases of early PVE 
– All cases of PVE and S. aureus 
– Late PVE 
• With heart failure caused by: 
– Prosthetic dehiscence 
– Prosthetic obstruction 
– Other indications of surgery 
• With perianular extension (abscess or fistulous tract) 
• With persistent bacteremia, recurrent emboli, or 
relapsing infection while on appropriate antibiotics
Timing of Surgery 
• Emergency (within 24 h): 
– Native (mitral or aortic) or prosthetic valve 
endocarditis and severe CHF or Cardiogenic Shock: 
• Acute valvular regurgitation 
• Severe prosthetic dysfunction (dehiscence or 
obstruction) 
• Fistula into a cardiac chamber or the pericardial space
Timing of Surgery 
• Urgent (within days): 
– NVE or PVE with: 
• Persisting CHF 
• Signs of poor hemodynamic tolerance 
• Abscess 
– PVE caused by: 
• Staph 
• Gram-negative organisms 
– Large vegetation (> 10 mm) with: 
• An embolic event 
• Other predictors of a complicated course 
– Very large vegetations (> 15 mm) 
– Large abscess and/or perianular involvement with uncontrolled 
infection
Timing of Surgery 
• Early Elective Surgery (During In-Hospital Stay): 
– Severe AR or MR with CHF and good response to 
antibiotic therapy 
– PVE with valvular dehiscence or CHF and good 
response to medical therapy 
– Presence of abscess or perianular extension 
– Persisting infection when extracardiac focus has been 
excluded 
– Fungal or other infections resistant to medical therapy
Surgical Approach 
• Considerations: 
– Aortic valve IE: 
• Anterior leaflet of mitral valve and its chordae should 
be examined for drop lesions 
• There might be a need for the left atrium to be entered 
to examine the posterior leaflet apparatus 
– Mitral valve IE: 
• Aortic valve involvement is unlikely if: 
– Absence of thrill or murmur 
– Competent aortic valve 
– No echo evidence of vegetations
Surgical Approach 
• Mitral Valve IE: 
– Posteroinferior portion of the mitral annulus 
should be inspected to look for myocardial ring 
abscess 
• Aortic Root Abscess: 
– Posterior to the membranous portion of IVS 
– Posterior portion of the septum anterior to the 
LMCA
Surgical Approach 
• Mitral Valve Endocarditis 
– Repair: 
• Healed, Small, or Discrete 
Vegetations 
• Does not involve a major 
portion of the tensor apparatus 
• How: 
– Closure of small defects of the 
anterior or posterior leaflet using 
autologus or bovine pericardium 
or direct suturing 
– Small vegetations might be 
stripped off the chordae 
tendineae
Surgical Approach 
• Mitral Valve Endocarditis: 
– Major destructions: 
• Major challenge for repair 
• Options: 
– Replacement for all but small 
vegetations : there is a risk of PVE in 
the setting of active infection 
– Debridement of infected tissue > 
Sliding annuloplasty to reconstruct 
commissural areas 
– Partial leaflet resection and/or 
pericardial patch replacement might 
be needed 
– Suture annuloplasty is preferable to 
prosthetic ring. 
– Biodegradable rings have also been 
used in active infection setting and has 
been shown to be safe
Surgical Approach 
• Abscesses: 
– When found: should be completely evacuated and 
surrounded tissue debrided: 
– Atrioventricular/ventriculoarterial discontinuity is 
an important issue
Mitral Valve IE with Ring Abscess
Mitral Valve IE with Ring Abscess
Mitral Valve IE with Ring Abscess
Aortic Valve IE with Abscess
Aortic Valve IE with Abscess
Aortic Valve IE with Abscess
Choice of Devices 
• Aortic Valve: 
– Allograft 
– Other devices also have good outcome 
– When aortic root replacement is considered, allograft is not 
superior to other choices 
• Tricuspid: 
– Repair 
– Allograft 
• Mitral: 
– Repair 
– If not possible then Mechanical Valve 
• Recurrent Infections: 
– Cardiac Transplant
Post Operative Considerations 
• Vasoplegia 
• Diuresis and PEEP for Early Extubation 
• Renal Function 
• Antibiotics 
• Persistent Fever and Sepsis Despite 
Satisfactory Operation

More Related Content

What's hot

Acute pericarditis
Acute pericarditisAcute pericarditis
Acute pericarditis
حسين عزالدين
 
Constrictive pericarditis
Constrictive pericarditis Constrictive pericarditis
Constrictive pericarditis
Ramachandra Barik
 
Complications of MI and their managements
Complications of MI and their managementsComplications of MI and their managements
Complications of MI and their managements
Dr. Mishal Saleem
 
Chronic coronary syndrome
Chronic coronary syndromeChronic coronary syndrome
Chronic coronary syndrome
desktoppc
 
Infective endocarditis
Infective endocarditis Infective endocarditis
Infective endocarditis
Abimbola Akinpelu
 
Myocarditis
MyocarditisMyocarditis
Myocarditis
Shinjan Patra
 
Hypertrophic cardiomyopathy
Hypertrophic cardiomyopathyHypertrophic cardiomyopathy
Hypertrophic cardiomyopathyFuad Farooq
 
Infective endocarditis
Infective endocarditisInfective endocarditis
Infective endocarditisPratik Kumar
 
Infective endocarditis
Infective endocarditisInfective endocarditis
Infective endocarditisAmith Kumar
 
Complications of acute mi
Complications of acute miComplications of acute mi
Complications of acute mi
Amir Mahmoud
 
Pulmonary stenosis presentation
Pulmonary stenosis presentationPulmonary stenosis presentation
Pulmonary stenosis presentation
Nizam Uddin
 
Acute Coronary Syndrome (NSTEMI)
Acute Coronary Syndrome (NSTEMI) Acute Coronary Syndrome (NSTEMI)
Acute Coronary Syndrome (NSTEMI)
Muhammad Asim Rana
 
Conduction Disorders
Conduction DisordersConduction Disorders
Conduction Disorders
Eneutron
 
Hypertrophic cardiomyopathy
Hypertrophic cardiomyopathyHypertrophic cardiomyopathy
Hypertrophic cardiomyopathy
Dr.Deepika T
 
Restrictive cardiomyopathy
Restrictive cardiomyopathyRestrictive cardiomyopathy
Restrictive cardiomyopathy
Johnson Velukkaran
 
EBSTEIN ANOMALY
EBSTEIN ANOMALYEBSTEIN ANOMALY
Mitral valve prolapse
Mitral valve prolapseMitral valve prolapse
Mitral valve prolapse
Srinivas Kinjarapu
 
Infective Endocarditis
Infective EndocarditisInfective Endocarditis
Infective Endocarditis
Sameh Abdel-ghany
 
HOCM Hypertrophic cardiomyopathy
HOCM Hypertrophic cardiomyopathyHOCM Hypertrophic cardiomyopathy
HOCM Hypertrophic cardiomyopathy
Please hit like if you really liked my PPTs
 
Approach to patient with Dilated Cardiomyopathy
Approach to patient with Dilated CardiomyopathyApproach to patient with Dilated Cardiomyopathy
Approach to patient with Dilated Cardiomyopathy
Nizam Uddin
 

What's hot (20)

Acute pericarditis
Acute pericarditisAcute pericarditis
Acute pericarditis
 
Constrictive pericarditis
Constrictive pericarditis Constrictive pericarditis
Constrictive pericarditis
 
Complications of MI and their managements
Complications of MI and their managementsComplications of MI and their managements
Complications of MI and their managements
 
Chronic coronary syndrome
Chronic coronary syndromeChronic coronary syndrome
Chronic coronary syndrome
 
Infective endocarditis
Infective endocarditis Infective endocarditis
Infective endocarditis
 
Myocarditis
MyocarditisMyocarditis
Myocarditis
 
Hypertrophic cardiomyopathy
Hypertrophic cardiomyopathyHypertrophic cardiomyopathy
Hypertrophic cardiomyopathy
 
Infective endocarditis
Infective endocarditisInfective endocarditis
Infective endocarditis
 
Infective endocarditis
Infective endocarditisInfective endocarditis
Infective endocarditis
 
Complications of acute mi
Complications of acute miComplications of acute mi
Complications of acute mi
 
Pulmonary stenosis presentation
Pulmonary stenosis presentationPulmonary stenosis presentation
Pulmonary stenosis presentation
 
Acute Coronary Syndrome (NSTEMI)
Acute Coronary Syndrome (NSTEMI) Acute Coronary Syndrome (NSTEMI)
Acute Coronary Syndrome (NSTEMI)
 
Conduction Disorders
Conduction DisordersConduction Disorders
Conduction Disorders
 
Hypertrophic cardiomyopathy
Hypertrophic cardiomyopathyHypertrophic cardiomyopathy
Hypertrophic cardiomyopathy
 
Restrictive cardiomyopathy
Restrictive cardiomyopathyRestrictive cardiomyopathy
Restrictive cardiomyopathy
 
EBSTEIN ANOMALY
EBSTEIN ANOMALYEBSTEIN ANOMALY
EBSTEIN ANOMALY
 
Mitral valve prolapse
Mitral valve prolapseMitral valve prolapse
Mitral valve prolapse
 
Infective Endocarditis
Infective EndocarditisInfective Endocarditis
Infective Endocarditis
 
HOCM Hypertrophic cardiomyopathy
HOCM Hypertrophic cardiomyopathyHOCM Hypertrophic cardiomyopathy
HOCM Hypertrophic cardiomyopathy
 
Approach to patient with Dilated Cardiomyopathy
Approach to patient with Dilated CardiomyopathyApproach to patient with Dilated Cardiomyopathy
Approach to patient with Dilated Cardiomyopathy
 

Viewers also liked

Infective endocarditis
Infective endocarditisInfective endocarditis
Infective endocarditis
Abhinav Srivastava
 
Infective Endocarditis
Infective EndocarditisInfective Endocarditis
Infective Endocarditis
Centro Escolar University-Makati
 
2015 ESC Guidelines on Infective Endocarditis ppt. by Dr Abhishek Rathore MD
2015 ESC Guidelines on Infective Endocarditis ppt. by Dr Abhishek Rathore MD2015 ESC Guidelines on Infective Endocarditis ppt. by Dr Abhishek Rathore MD
2015 ESC Guidelines on Infective Endocarditis ppt. by Dr Abhishek Rathore MD
drabhishekbabbu
 
Infective endocarditis
Infective endocarditisInfective endocarditis
Infective endocarditis
Azad Haleem
 
Endocarditis 2015
Endocarditis  2015Endocarditis  2015
Endocarditis 2015
samirelansary
 
Cardiomyopathies
CardiomyopathiesCardiomyopathies
Cardiomyopathies
gku1990
 
Early surgery for infective endocarditis
Early surgery for infective endocarditisEarly surgery for infective endocarditis
Early surgery for infective endocarditispkhohl
 
Endocarditis 2015
Endocarditis  2015Endocarditis  2015
Endocarditis 2015
samirelansary
 
Infective endocarditis
Infective endocarditisInfective endocarditis
Infective endocarditis
hodmedicine
 
Rheumatic fever
Rheumatic fever Rheumatic fever
Rheumatic fever
Avelin D'Souza
 
Infective endocarditis
Infective endocarditisInfective endocarditis
Infective endocarditisfracpractice
 
Cardiovascular disorders
Cardiovascular disordersCardiovascular disorders
Cardiovascular disordersgchoyer
 
Infective endocarditis
Infective endocarditisInfective endocarditis
Infective endocarditispochao
 
Infective endocarditis@ghanem@
Infective endocarditis@ghanem@Infective endocarditis@ghanem@
Infective endocarditis@ghanem@
Islam Ghanem
 
Rhabdomyolysis
RhabdomyolysisRhabdomyolysis
Rhabdomyolysis
Wahid altaf Sheeba hakak
 
Rheumatic Fever
Rheumatic FeverRheumatic Fever
Rheumatic Fever
Dr. Muhammad Imran
 

Viewers also liked (20)

Infective endocarditis
Infective endocarditisInfective endocarditis
Infective endocarditis
 
A Case of Infective Endocarditis
A Case of Infective EndocarditisA Case of Infective Endocarditis
A Case of Infective Endocarditis
 
Infective Endocarditis
Infective EndocarditisInfective Endocarditis
Infective Endocarditis
 
2015 ESC Guidelines on Infective Endocarditis ppt. by Dr Abhishek Rathore MD
2015 ESC Guidelines on Infective Endocarditis ppt. by Dr Abhishek Rathore MD2015 ESC Guidelines on Infective Endocarditis ppt. by Dr Abhishek Rathore MD
2015 ESC Guidelines on Infective Endocarditis ppt. by Dr Abhishek Rathore MD
 
Infective endocarditis
Infective endocarditisInfective endocarditis
Infective endocarditis
 
Endocarditis 2015
Endocarditis  2015Endocarditis  2015
Endocarditis 2015
 
Cardiomyopathies
CardiomyopathiesCardiomyopathies
Cardiomyopathies
 
Early surgery for infective endocarditis
Early surgery for infective endocarditisEarly surgery for infective endocarditis
Early surgery for infective endocarditis
 
Endocarditis 2015
Endocarditis  2015Endocarditis  2015
Endocarditis 2015
 
Infective endocarditis
Infective endocarditisInfective endocarditis
Infective endocarditis
 
Rheumatic fever
Rheumatic fever Rheumatic fever
Rheumatic fever
 
Infective endocarditis
Infective endocarditisInfective endocarditis
Infective endocarditis
 
Cardiovascular disorders
Cardiovascular disordersCardiovascular disorders
Cardiovascular disorders
 
Endocarditis
EndocarditisEndocarditis
Endocarditis
 
Infective endocarditis
Infective endocarditisInfective endocarditis
Infective endocarditis
 
Infective Endocarditis
Infective EndocarditisInfective Endocarditis
Infective Endocarditis
 
Endocarditis
EndocarditisEndocarditis
Endocarditis
 
Infective endocarditis@ghanem@
Infective endocarditis@ghanem@Infective endocarditis@ghanem@
Infective endocarditis@ghanem@
 
Rhabdomyolysis
RhabdomyolysisRhabdomyolysis
Rhabdomyolysis
 
Rheumatic Fever
Rheumatic FeverRheumatic Fever
Rheumatic Fever
 

Similar to Infective Endocarditis and It's Surgical Management

2.3. IE.ppt
2.3. IE.ppt2.3. IE.ppt
2.3. IE.ppt
AmareDejene
 
Infective endocarditis
Infective endocarditisInfective endocarditis
Infective endocarditis
Kalpana Gogoi
 
Infective endocarditis
Infective endocarditisInfective endocarditis
Infective endocarditis
Engidaw Ambelu
 
INFECTIVE ENDOCARDITITS
INFECTIVE ENDOCARDITITSINFECTIVE ENDOCARDITITS
INFECTIVE ENDOCARDITITS
Aamir Hela
 
infectious endocarditis.pptx
infectious endocarditis.pptxinfectious endocarditis.pptx
infectious endocarditis.pptx
RAHULSUTHAR46
 
Infective endocarditis
Infective endocarditisInfective endocarditis
Infective endocarditis
johnedward869
 
Infective endocarditis
Infective endocarditisInfective endocarditis
Infective endocarditis
AndrewCrofton
 
Infective endocarditis
Infective endocarditisInfective endocarditis
Infective endocarditisPratik Kumar
 
Infective Encocarditis by Sunil Kumar Daha
Infective Encocarditis by Sunil Kumar DahaInfective Encocarditis by Sunil Kumar Daha
Infective Encocarditis by Sunil Kumar Daha
sunil kumar daha
 
Infective endocarditis
Infective endocarditis Infective endocarditis
Infective endocarditis
Kailas Nath
 
Endocarditis april 2018
Endocarditis  april 2018Endocarditis  april 2018
Endocarditis april 2018
Meher Rizvi
 
Infective endocarditis
Infective endocarditisInfective endocarditis
Infective endocarditis
pediatricsmgmcri
 
Cardiovascular system infections by Rakesh Prasad Sah
Cardiovascular system infections by Rakesh Prasad SahCardiovascular system infections by Rakesh Prasad Sah
Cardiovascular system infections by Rakesh Prasad Sah
Dr. Rakesh Prasad Sah
 
04 cardiac pathology
04 cardiac pathology04 cardiac pathology
04 cardiac pathology
med_students0
 
Endocarditis and its management
Endocarditis and its managementEndocarditis and its management
Endocarditis and its management
Shweta Sharma
 
Endocarditis
EndocarditisEndocarditis
Endocarditis
Pedram Doulabi
 
Infective endocarditis
Infective endocarditisInfective endocarditis
Infective endocarditis
kopilaray
 
INFECTIVE ENDOCARDITIS FMCJ.pptx
INFECTIVE ENDOCARDITIS FMCJ.pptxINFECTIVE ENDOCARDITIS FMCJ.pptx
INFECTIVE ENDOCARDITIS FMCJ.pptx
OyovwiPedro1
 
MI, RHD.pptx
MI, RHD.pptxMI, RHD.pptx
MI, RHD.pptx
SumanjitDas1
 

Similar to Infective Endocarditis and It's Surgical Management (20)

2.3. IE.ppt
2.3. IE.ppt2.3. IE.ppt
2.3. IE.ppt
 
Infective endocarditis
Infective endocarditisInfective endocarditis
Infective endocarditis
 
Infective endocarditis
Infective endocarditisInfective endocarditis
Infective endocarditis
 
INFECTIVE ENDOCARDITITS
INFECTIVE ENDOCARDITITSINFECTIVE ENDOCARDITITS
INFECTIVE ENDOCARDITITS
 
infectious endocarditis.pptx
infectious endocarditis.pptxinfectious endocarditis.pptx
infectious endocarditis.pptx
 
Infective endocarditis
Infective endocarditisInfective endocarditis
Infective endocarditis
 
Infective endocarditis
Infective endocarditisInfective endocarditis
Infective endocarditis
 
Infective endocarditis
Infective endocarditisInfective endocarditis
Infective endocarditis
 
Infective Encocarditis by Sunil Kumar Daha
Infective Encocarditis by Sunil Kumar DahaInfective Encocarditis by Sunil Kumar Daha
Infective Encocarditis by Sunil Kumar Daha
 
Infective endocarditis
Infective endocarditis Infective endocarditis
Infective endocarditis
 
Endocarditis april 2018
Endocarditis  april 2018Endocarditis  april 2018
Endocarditis april 2018
 
Infective endocarditis
Infective endocarditisInfective endocarditis
Infective endocarditis
 
Endocarditis
EndocarditisEndocarditis
Endocarditis
 
Cardiovascular system infections by Rakesh Prasad Sah
Cardiovascular system infections by Rakesh Prasad SahCardiovascular system infections by Rakesh Prasad Sah
Cardiovascular system infections by Rakesh Prasad Sah
 
04 cardiac pathology
04 cardiac pathology04 cardiac pathology
04 cardiac pathology
 
Endocarditis and its management
Endocarditis and its managementEndocarditis and its management
Endocarditis and its management
 
Endocarditis
EndocarditisEndocarditis
Endocarditis
 
Infective endocarditis
Infective endocarditisInfective endocarditis
Infective endocarditis
 
INFECTIVE ENDOCARDITIS FMCJ.pptx
INFECTIVE ENDOCARDITIS FMCJ.pptxINFECTIVE ENDOCARDITIS FMCJ.pptx
INFECTIVE ENDOCARDITIS FMCJ.pptx
 
MI, RHD.pptx
MI, RHD.pptxMI, RHD.pptx
MI, RHD.pptx
 

Recently uploaded

Light House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat EuropeLight House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat Europe
Lighthouse Retreat
 
Top-Vitamin-Supplement-Brands-in-India.pptx
Top-Vitamin-Supplement-Brands-in-India.pptxTop-Vitamin-Supplement-Brands-in-India.pptx
Top-Vitamin-Supplement-Brands-in-India.pptx
SwisschemDerma
 
Gram Stain introduction, principle, Procedure
Gram Stain introduction, principle, ProcedureGram Stain introduction, principle, Procedure
Gram Stain introduction, principle, Procedure
Suraj Goswami
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
Dr. Rabia Inam Gandapore
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
greendigital
 
A Classical Text Review on Basavarajeeyam
A Classical Text Review on BasavarajeeyamA Classical Text Review on Basavarajeeyam
A Classical Text Review on Basavarajeeyam
Dr. Jyothirmai Paindla
 
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in DehradunDehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
chandankumarsmartiso
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Prof. Marcus Renato de Carvalho
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
MedicoseAcademics
 
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMSAdv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
AkankshaAshtankar
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
KafrELShiekh University
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
vimalpl1234
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Vision-1.pptx, Eye structure, basics of optics
Vision-1.pptx, Eye structure, basics of opticsVision-1.pptx, Eye structure, basics of optics
Vision-1.pptx, Eye structure, basics of optics
Sai Sailesh Kumar Goothy
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
suvadeepdas911
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
NEHA GUPTA
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
NephroTube - Dr.Gawad
 

Recently uploaded (20)

Light House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat EuropeLight House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat Europe
 
Top-Vitamin-Supplement-Brands-in-India.pptx
Top-Vitamin-Supplement-Brands-in-India.pptxTop-Vitamin-Supplement-Brands-in-India.pptx
Top-Vitamin-Supplement-Brands-in-India.pptx
 
Gram Stain introduction, principle, Procedure
Gram Stain introduction, principle, ProcedureGram Stain introduction, principle, Procedure
Gram Stain introduction, principle, Procedure
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
 
A Classical Text Review on Basavarajeeyam
A Classical Text Review on BasavarajeeyamA Classical Text Review on Basavarajeeyam
A Classical Text Review on Basavarajeeyam
 
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in DehradunDehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
 
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMSAdv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 
Vision-1.pptx, Eye structure, basics of optics
Vision-1.pptx, Eye structure, basics of opticsVision-1.pptx, Eye structure, basics of optics
Vision-1.pptx, Eye structure, basics of optics
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
 

Infective Endocarditis and It's Surgical Management

  • 2. Definition • Conditions in which structures of the heart, most frequently the valves, harbor an infective process. • This might lead to: – Valvar dysfunction – Localized or generalized sepsis – Sites for embolism • The term “Infective Endocarditis” includes: – Acute, subacute, and chronic – Bacterial, viral, rickettsial, or fungal – Native or prosthetic
  • 3. Definition • Endocarditis: – Exudative and proliferative inflammatory alterations of the endocardium – Characterized by vegetations on the endocardial surface or within the endocardium – May occur as the primary disorder (infective endocarditis) or as a secondary complication of another disease (SLE, Rheumatic Heart Disease)
  • 4. Definition • Infective Endocarditis: – Invasion and multiplication of micro-organisms on the endocardial surface, within the endocardium, within the myocardium, or on prosthetic materials within and around cardiac structures – Most frequently involves the valvar structures and it may lead to destruction of these structures, localized or genertalized sepsis, or sites of embolism
  • 5. Pathogenesis • The most common site of involvement is on the line of closure of the valves – Atrial side of the atrio-ventricular valves – Ventricular side of the semilunar valves • Maturation of the vegetation: – Bacterial attachment – Bacterial proliferation + fibrin deposition • The bacteria remain below the surface of the vegetation and this protects them from: – Phagocytes – High antibiotic concentrations
  • 6. Pathogenesis • Altered Endocardial Surface to allow deposition of bacteria and fibrin: – Rheumatic Valvulitis – Annular or Valvar Calcification – Catheter Trauma • Haemodynamic Factors: – Jet effect of blood flow through • PDA • Restrictive VSD • Mitral Valve Prolapse • BAV • Bacteraemia : 60-80% of normal individuals
  • 7. Pathogenesis • Compromised or Altered Immune System – Histopathologic analysis of kidney tissue of the patients with IE: • Diffuse proliferative glumerolonephritis • Evidence of deposition of IgG and IgM • Circulating immune complexes (CICs) may be found in the: – Glomerular basement membrane – Retina – Peripheral lesions (Janeway lesions and Roth Spots) • CIC Levels correlate with the duration of the illness • Drop in CIC levels correlate with the success of the treatment – Various manifestations of complement activation
  • 8. Pathogenesis • 25% of IE happen in normal valves – Organisms involved are those with increased adhesions molecules: • Staphylococcus • Streptococcus Viridans • Enterococcus – Common Risk Factors: • Overwhelming Sepsis • Resuscitation from Shock • Use of Long-Term IDCs • IVDU • Fungemia associated with prolonged ABx use • Only 5% of patients with IDC sepsis have endocarditis and it is usually due to Staphylococcal Organisms.
  • 9. Pathogenesis • Iathrogenic IE: – Those undergoing chronic hemodialysis – Frequent Staphylococcal bacteremia – Sclerotic Aortic/Mitral Valves
  • 10. Rodbard Hypothesis for Pathogenesis PART III Acquired Valvar 674 Heart Disease Orifice Sink Vena contracta Source Figure 15-1 Flow through a permeable tube. High-pressure source drives fluid through an orifice into a low-pressure sink. Curved arrows leaving the stream entering wall in upstream segment rep-resent normal perfusion of lining layer. Velocity is maximal and perfusing pressure is low immediately beyond orifice, where momentum of stream converges stream lines to form a vena con-tracta. Low pressure in this segment results in reduced perfusion and may cause retrograde flow from deeper layers of vessel into the flowing stream. It is at the vena contracta that bacteria and other formed elements in blood accumulate. (From Rodbard.R4) • High velocity jets of blood from a high-pressure source form at an orifice and enter a low-pressure sink • Venturi currents deposit bacteria immediately beyond the orifice to form vena contracta and result in mechanical erosion and deposition of platelets and thrombin
  • 11. Pathogenesis • The same mechanism exists – Against the stenotic valves – Opposite to a PDA in pulmonary artery – Left atrial side of the regurgitant mitral valve. • Most IE lesions of aortic valve happen on the ventricular side which suggest the a role for valvar regurgitation and also the venturi effect
  • 12. Morphology • Vegetations and eorsive cavities are on the: – Ventricular aspect of the aortic valve cusps – Base of the atrial side of the mitral valve leaflets • Often causing separation or discontinuity at the – Ventriculoarterial junction – Atrioventricular junction – Drop Lesions from the aortic valve vegetations occur on the anterior leaflet of the mitral valve and the tensor apparatus. – Discrete perforations also occur by isolated vegetations.
  • 13. Aortic valve with vegetation on non-coronary cusp and partial destruction of left coronary cusp.
  • 14. Aortic valve with vegetation between non-coronary and right coronary cusps extending as an anular abscess
  • 15. Leaflet vegetation and ring abscess of posterior medial aspect of mitral valve
  • 16. Mitral valve with drop lesion of anterior leaflet
  • 17. Morphology • NVE: – Non-IV-Drug-Related: • Left Sided – IV-Drug-Related: • Tricuspid Valve 50% • Aortic and Mitral 50% • Perianular Abscess (Pseudoaneurysm): – More common with aortic valve endocarditis than it is with mitral – It is present in 1/3 of cases studied with TOE – Predominant organism is : S. aureus – Clinical features: • Presence of pericarditis • Rapid progression of the disease • High degree of AV Block
  • 18. Morphology • PVE: – All or most of the vegetations are on the ventricular aspect – Only a small area of sewing ring detachment might be apparent and it might appear sterile – A thorough search at operation must be made beneath the valve to identify the bulk of the pathologic process – There may be important detachment without vegetation. This might be in the absence of an abscess or even positive blood culture.
  • 19. Loci of Infective Endocarditis Lesions
  • 20. Clinical Features • IE is present when – Positive blood cultures associated with: • New or changing murmurs • Embolic phenomena – New or changing murmurs in a patient with congenital cardiac anomaly or prior valve damage associated with: • Embolic phenomena • Sustained fever, anemia, and splenomegaly – Some authorities also accept the presence of progressive heart failure in the presence of positive blood cultures.
  • 21. Duke’s Criteria - Major • Positive blood culture – Typical MOs for IE from 2 separate blood cultures in the absence of a primary focus: • Strep Viridans, Strep Bovis, HACEK (Haemophilus, Actinobacillus, Cardiobacterium, Eikenella, and Kingella), Community-acquired staph aureus, or Enterococci – Persistently positive blood cultures, defined as recovery of a microorganism consistent with IE from: • Blood cultures drawn more than 12 hours apart • All of three or majority of 4 or more separate blood cultures with first and last drawn at least 1 hour apart
  • 22. Duke’s Criteria - Major • Evidence of Endocardial Involvement: – Positive echocardiogram for infective endocarditis: • Oscillating intra-cardiac mass in absence of an alternative anatomic explanation: – On valve or supporting structures – In path of regurgitant jets – On implanted material • Abscess • New partial dehiscence of prosthetic valve • New valvar regurgitation (increase or change in preexisting murmur not sufficient for diagnosis)
  • 23. Duke’s Criteria - Minor • Predisposition: – Predisposing heart condition or IV drug use – Fever ≥38°C • Vascular Phenomena: – Major arterial emboli – Septic pulmonary infarcts – Mycotic aneurysm – Intracranial hemorrhage – Conjunctival hemorrhages – Janeway lesions
  • 24. Duke’s Criteria - Minor • Immunologic Phenomena: – Glomerulonephritis – Osler nodes – Roth spots – Rheumatoid factor
  • 25. Duke’s Criteria - Minor • Microbiological Evidence: – Positive blood cultures but not meeting the major criterion – Serologic evidence of active infection with a MO consistent with IE • Echocardiogram: – Consistent with infective endocarditis but not meeting major criterion
  • 26. Clinical Feature • Fever: – The most common clinical manifestation – 95-100% present – Low-grade – Spiking – Following the peak of bacteremia by 2 hours – Those at risk of IE who develop fever for more than 48 hours should have 2 or more sets of blood cultures drawn from different sites • Positive blood cultures: – 95% of cases even when those with right-sided IE, fungal IE, IE in addicts, IE caused by fastidious organisms are included. • Culture negative IE: 10% – Mostly in those with PVE – Intracellular or fastidious organisms – Previous antibiotic therapy – A history of AB therapy and serologic evidence of mycoplasma, or chlamydia – Other causes: • Aspergillus, Q-fever, Bartonella
  • 27. Clinical Feature • Heart Murmur: – 85-95% – 10% lack murmur – Aortic root and valve: • Short Diastolic Murmur • Early systolic or midsystolic murmurs also can be present – Mitral valve: • Like other MR, systolic murmurs and in the case of anterior leaflet drop lesions there is a distinct radiation to the back. • Diastolic murmurs like MS: obstruction with large vegetation. • Anemia – Multifactorial causes: Marrow suppression as a result of the chronic disease • Arthralgia / Arthritis : rarely seen today as a result of earlier diagnosis of the condition • Myalgia: common – Associated with bacteremia – Occasionally may result from myocardial microabscesses which generally happen in staph bacteremia
  • 28. Clinical Feature • Embolic Phenomenon: – 10-15% presenting manifestation – 50% of patients with IE have embolic phenomenon: • Diagnosed on either clinical examination or by an imaging modality • Evenly distributed between cerebral and peripheral sites • Classic ones are now rarely seen in surgical practice: – Osler Nodes – Janeway Lesions : Staph almost always is the organism – Roth Spots – Petechiae – Clubbing • Neurologic Abnormalities: 25-30% of patients at initial presentation: – TIA/Stroke/Loss of Vision/Seizures/Headache/Backache/Acute Mononeuropathy
  • 29. Causative Organisms • Strep and Staph : 80% of cases – S. aureus: • The most common cause of IE amongst hospital-acquired and drug-related • Mitral > Aortic • Higher occurrence of embolism comparing to the other oranisms – Strep: • 30% of IE cases • Viridans is the most common • Enterococci: – The third common – 10% of cases – Elderly male – Multiple comorbidities – Less common embolic events – More avidity to Aortic Valve • Gram-negative bacilli: – 5% of cases
  • 30. Causative Organisms • PVE: – 2 months post-op: Staph. Epidermidis – Late onset: as NVE – Enterococcal: • E. Faecalis/ E. Faecium • Associated with manipulation of GI or GU tract • GI or GU tract malignancy
  • 31. Complications • Heart Failure • Renal • Embolic Events • Neurologic Manifestations
  • 32. Heart Failure • The most common • Valvular regurgitation is the cause • NVE occasionally results is MS and/or TS and infrequently AS • Perianular Extension – Major causes of heart failure in PVE. – 50% of cases with PVE – 10-40% of NVE – More commonly involves the aortic valve – Can lead to: • Abscess formation / pseudoaneurysm/aortocavitary fistula • Myocardial abscess: – S. aureus – PVE / Aortic Valve / BAV – Development of conduction abnormalities should prompt further TOE examination – Untreated: fistula formation and intracardiac shunting from myocardial perforation
  • 33. Renal • At least in 4 forms: – Pre-renal due to low cardiac output – Microabscess formation secondary to septic emboli – Golmerular dysfunction as a result of CIC – Renal failure as a result of ABx
  • 34. Embolic Events • Common: – NVE : 43% – IV Drug-Associated : 67% – PVE: 25%
  • 35. Embolic Events • Metastatic infection of viscera is typically caused by Staph. • Multiple Coronary emboli: – MI – Ventricular Dysfunction – Most common causative organisms: • S. Aureus • Candida • HACEK (Hemophilus, Actinobacillus, Cardiobacterium, Eikenella, Kingella) • Neurologic Manifestations: – 50% of embolic complications are associated with neurologic manifestations – 1/4 – 1/3 of patients with NVE or PVE at some time have neurologic complications of which 90% are related to emboli in the territory of MCA – S. aureus increases the risk – Stroke is the most common neurologic event
  • 36. Embolic Neurologic Events • Cerebral embolism generally happens before the start of antibiotic therapy and the risk dramatically falls following the commencement of an effective therapy. – The risk falls from ~ 12% to 4% • The absolute size of vegetation and failure of decrease in size of the vegetation following ABx is a risk for embolization. • HACEK Group and fungi create the large vegetation.
  • 37. Intracerebral Hemorrhage • The most devastating complication • 5% of IE • 50% mortality • Pathophysiology: – Septic arteritis with erosion of the vessel wall during uncontrolled infection – Hemorrhage following infarction – Rupture of mycotic aneurysm
  • 38. Treatment • Antibiotics: – > 50% of cases can be managed solely with antibiotics – Once antibiotics started blood cultures should be taken every 1- 2 days and the length of the treatment should be calculated based on the date the blood cultures have become negative • Surgery: – It is necessary in 40-45% of patients – Goals: • Remove infected tissues and drain abscesses • Restore or reconstruct atrioventricular or ventriculo-arterial continuity • Reverse the haemodynamic abnormality • Closing the acquired defect / in children: repair of congenital malformation
  • 39. Indications for Surgery • NVE: – Healed: those hemodynamic indications present for those without IE and similar valvular lesions – Active: • Congestive Heart Failure • Perianular Extension • Systemic Embolism • Cerebrovascular Complications • Persistent Sepsis • Difficult Organisms • PVE
  • 40. Indications for Surgery • Congestive Heart Failure: – Caused by severe aortic or mitral regurgitation, more rarely by valve obstruction caused by vegetations. – Severe acute aortic or mitral regurgitation with echocardiographic signs of elevated left ventricular end-diastolic pressure or significant pulmonary hypertension. – As a result of prosthetic dehiscence or obstruction.
  • 41. Indications for Surgery • Perianular Extension • Systemic Embolism – Recurrent emboli despite appropriate antibiotic therapy. – Large vegetations (>10 mm) after one or more clinical or silent embolic events after initiation of antibiotic therapy – Large vegetations and other predictors of a complicated course – Very large vegetations (>15 mm) without embolic complications, especially if valve-sparing surgery is likely (remains controversial)
  • 42. Indications for Surgery • Cerebrovascular Complications – Silent neurologic complication or TIA and other surgical indications – Ischemic stroke and other surgical indications (hemorrhage should have been excluded and the neurologic complications are not severe and there is a chance for recovery)
  • 43. Indications for Surgery • Persistent Sepsis: – Fever or positive blood cultures persisting > 5-7 days despite appropriate antibiotic regimen, assuming that vegetations or other cardiac lesions requiring surgery persist and extracardiac sources of sepsis have all been excluded – Relapsing infective endocarditis, esp. when caused by organisms other than sensitive strep or in patients with prosthetic valves
  • 44. Indications for Surgery • Difficult Organisms: – S. aureus involving a prosthetic valve and most cases involving a native valve – IE caused by other aggressive organisms: • Brucella • Stpahylococcus Lugdunensis – IE caused by MRO: • MRSA • VRE – P. aeruginosa IE – Fungal IE – Q Fever IE at the presence of other indications for intervention
  • 45. Indications for Surgery • Prosthetic valve endocarditis: – All cases of early PVE – All cases of PVE and S. aureus – Late PVE • With heart failure caused by: – Prosthetic dehiscence – Prosthetic obstruction – Other indications of surgery • With perianular extension (abscess or fistulous tract) • With persistent bacteremia, recurrent emboli, or relapsing infection while on appropriate antibiotics
  • 46. Timing of Surgery • Emergency (within 24 h): – Native (mitral or aortic) or prosthetic valve endocarditis and severe CHF or Cardiogenic Shock: • Acute valvular regurgitation • Severe prosthetic dysfunction (dehiscence or obstruction) • Fistula into a cardiac chamber or the pericardial space
  • 47. Timing of Surgery • Urgent (within days): – NVE or PVE with: • Persisting CHF • Signs of poor hemodynamic tolerance • Abscess – PVE caused by: • Staph • Gram-negative organisms – Large vegetation (> 10 mm) with: • An embolic event • Other predictors of a complicated course – Very large vegetations (> 15 mm) – Large abscess and/or perianular involvement with uncontrolled infection
  • 48. Timing of Surgery • Early Elective Surgery (During In-Hospital Stay): – Severe AR or MR with CHF and good response to antibiotic therapy – PVE with valvular dehiscence or CHF and good response to medical therapy – Presence of abscess or perianular extension – Persisting infection when extracardiac focus has been excluded – Fungal or other infections resistant to medical therapy
  • 49. Surgical Approach • Considerations: – Aortic valve IE: • Anterior leaflet of mitral valve and its chordae should be examined for drop lesions • There might be a need for the left atrium to be entered to examine the posterior leaflet apparatus – Mitral valve IE: • Aortic valve involvement is unlikely if: – Absence of thrill or murmur – Competent aortic valve – No echo evidence of vegetations
  • 50. Surgical Approach • Mitral Valve IE: – Posteroinferior portion of the mitral annulus should be inspected to look for myocardial ring abscess • Aortic Root Abscess: – Posterior to the membranous portion of IVS – Posterior portion of the septum anterior to the LMCA
  • 51. Surgical Approach • Mitral Valve Endocarditis – Repair: • Healed, Small, or Discrete Vegetations • Does not involve a major portion of the tensor apparatus • How: – Closure of small defects of the anterior or posterior leaflet using autologus or bovine pericardium or direct suturing – Small vegetations might be stripped off the chordae tendineae
  • 52. Surgical Approach • Mitral Valve Endocarditis: – Major destructions: • Major challenge for repair • Options: – Replacement for all but small vegetations : there is a risk of PVE in the setting of active infection – Debridement of infected tissue > Sliding annuloplasty to reconstruct commissural areas – Partial leaflet resection and/or pericardial patch replacement might be needed – Suture annuloplasty is preferable to prosthetic ring. – Biodegradable rings have also been used in active infection setting and has been shown to be safe
  • 53. Surgical Approach • Abscesses: – When found: should be completely evacuated and surrounded tissue debrided: – Atrioventricular/ventriculoarterial discontinuity is an important issue
  • 54. Mitral Valve IE with Ring Abscess
  • 55. Mitral Valve IE with Ring Abscess
  • 56. Mitral Valve IE with Ring Abscess
  • 57. Aortic Valve IE with Abscess
  • 58. Aortic Valve IE with Abscess
  • 59. Aortic Valve IE with Abscess
  • 60. Choice of Devices • Aortic Valve: – Allograft – Other devices also have good outcome – When aortic root replacement is considered, allograft is not superior to other choices • Tricuspid: – Repair – Allograft • Mitral: – Repair – If not possible then Mechanical Valve • Recurrent Infections: – Cardiac Transplant
  • 61. Post Operative Considerations • Vasoplegia • Diuresis and PEEP for Early Extubation • Renal Function • Antibiotics • Persistent Fever and Sepsis Despite Satisfactory Operation

Editor's Notes

  1. If perianular abscess/pseudoaneurysm/ fistula and shunts develop the mortality exceeds 40% despite surgical intervention Pericarditis also occurs in the setting of anular abscess or myocardial perforation
  2. Pre-renal Spread of infection CIC Iathrogenic : ABx